Following their most recent IPO, Morgans Analyst Scott Power has initiated coverage on Control Bionics (ASX:CBL).

CBL is a health technology company, providing the ability for patients who live with Motor Neuron Disease, Multiple Sclerosis and Cerebral Palsy to operate computers and software through the use of visual or neural signals.

Check out more from Morgans:
Visit the Morgans website: www.morgans.com.au
Check out our blog: www.morgans.com.au/Blog

On Facebook: www.facebook.com/MorgansAU
On Instagram: www.instagram.com/morgans.australia
On Twitter: twitter.com/morgansAU